부산대학교 도서관

Gentile G; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Brussels, Belgium; Department of Experimental Medicine, Sapienza University, Rome, Italy.; Gerosa R; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Brussels, Belgium; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.; de Azambuja E; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Brussels, Belgium.; Piccart-Gebhart M; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Brussels, Belgium. Electronic address: martine.piccart@hubruxelles.be.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Gerosa R; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy. Electronic address: https://twitter.com/RGerosaMD.; Gentile G; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium; Department of Radiological, Oncological and Pathological Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy. Electronic address: https://twitter.com/gabri_gentilee.; Arecco L; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium. Electronic address: https://twitter.com/Lucarecco.; Dauccia C; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy. Electronic address: https://twitter.com/ChiaraDauccia.; Nannini S; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium.; Lobo-Martins S; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium. Electronic address: https://twitter.com/S_LoboMartins.; Agostinetto E; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium. Electronic address: https://twitter.com/ElisaAgostinett.; Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy; Department of Medical Oncology, UOC Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Santoro A; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Department of Hematology and Oncology, Humanitas Cancer Center, Humanitas Clinical and Research Center, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rozzano, Milan, Italy.; Aftimos P; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium. Electronic address: https://twitter.com/aftimosp.; Piccart-Gebhart M; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium.; de Azambuja E; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium. Electronic address: evandro.deazambuja@hubruxelles.be.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Goldhirsch, A; Winer, EP; Coates, AS; Gelber, RD; Piccart-Gebhart, M; Thuerlimann, B; Senn, H-J

ANNALS OF ONCOLOGY. 24(9):2206-2223

Burstein, H J; Curigliano, G; Loibl, S; Dubsky, P; Gnant, M; Poortmans, P; Colleoni, M; Denkert, C; Piccart-Gebhart, M; Regan, M; Senn, H -J; Winer, E P; Thurlimann, B; 2019, Members of the St. Gallen International Consensus Panel on the Primary Therapy of Early Breast Cancer

Annals of Oncology. Oct2019, Vol. 30 Issue 10, p1541-1557. 17p. 8 Charts, 1 Graph.

Holmes, E M; Bradbury, I; Williams, L S; Korde, L; Azambuja, E de; Fumagalli, D; Moreno-Aspitia, A; Baselga, J; Piccart-Gebhart, M; Dueck, A C; Gelber, R D; Team, ALTTO Trial Study

Annals of Oncology. Sep2019, Vol. 30 Issue 9, p1507-1513. 7p. 2 Charts, 3 Graphs.

de Azambuja E; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Service d'oncologie médicale, Brussels. Electronic address: evandro.deazambuja@hubruxelles.be.; Piccart-Gebhart M; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Brussels, Belgium.; Fielding S; Frontier Science (Scotland) Ltd., Kincraig, UK.; Townend J; Frontier Science (Scotland) Ltd., Kincraig, UK.; Hillman DW; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, USA.; Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy.; Roylance R; Department of Oncology, UCLH Foundation Trust, London, UK.; Kelly CM; Cancer Trials Ireland, Dublin, Ireland; Mater Private Hospital, Dublin, Ireland.; Lombard J; Breast Cancer Trials (Australia New Zealand), Newcastle, Australia.; El-Abed S; Breast International Group (BIG), Brussels, Belgium.; Choudhury A; Novartis Healthcare Pvt Ltd, Hyderabad, India.; Korde L; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, USA.; Vicente M; Institut Jules Bordet, Brussels, Belgium.; Chumsri S; Mayo Clinic, Jacksonville, USA.; Rodeheffer R; Mayo Clinic College of Medicine and Science, Rochester, USA.; Ellard SL; BC Cancer Kelowna, Kelowna, Canada.; Wolff AC; The Johns Hopkins Kimmel Cancer Center, Baltimore, USA.; Holtschmidt J; German Breast Group (GBG) Forschungs GmbH, Neu-Isenburg, Germany.; Lang I; Clinexpert Research, Gyongyos, Hungary.; Untch M; Helios Klinikum Berlin-Buch, Head of Clinic for Gynecology, Gynecologic Oncology and Obstetrics, Breast Cancer Center, Berlin, Germany; AGO B Study Group, Study Center of the Women's Clinic, Erlangen University Hospital, Erlangen, Germany.; Boyle F; Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital, North Sydney, Australia; University of Sydney, Sydney, Australia.; Xu B; National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Werutsky G; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.; Tujakowski J; Chemotherapy, Centre of Oncology, Bydgoszcz, Poland.; Huang CS; National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.; Baruch NB; Holy Family Hospital, Nazareth, Israel.; Bliss J; The Institute of Cancer Research, London, UK.; Ferro A; Breast Unit, Department of Medical Oncology, APSS, Trento, Italy.; Gralow J; American Society of Clinical Oncology, Alexandria, USA.; Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Kroep JR; Leiden University Medical Center, Leiden, The Netherlands.; Krop I; Yale Cancer Center, New Haven, Connecticut, USA.; Kuemmel S; Breast Unit, Kliniken Essen-Mitte, Essen; Clinic for Gynecology with Breast Center, Charité-Universitätsmedizin, Berlin, Germany.; McConnell R; Frontier Science (Scotland) Ltd., Kincraig, UK.; Moscetti L; Department of Oncology-Hematology, University Hospital of Modena, Modena; GOIRC (Gruppo Oncologico Italiano di Ricerca Clinica), Parma, Italy.; Knop AS; Department of Oncology, Copenhagen University Hospital, Copenhagen, Denmark.; van Duijnhoven F; Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Gomez H; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru.; Cameron D; Edinburgh University Cancer Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.; Di Cosimo S; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.; Gelber RD; Department of Data Science, Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Boston; Frontier Science Foundation, Boston, USA.; Moreno-Aspitia A; Mayo Clinic, Jacksonville, USA.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Dubsky, P; Curigliano, G; Burstein, H J; Winer, E P; Gnant, M; Loibl, S; Colleoni, M; Regan, M M; Piccart-Gebhart, M; Senn, H -J; Thürlimann, B; André, F; Baselga, J; Bergh, J; Bonnefoi, H; Brucker, S Y; Cardoso, F; Carey, L; Ciruelos, E; Cuzick, J; Denkert, C; Di Leo, A; Ejlertsen, B; Francis, P; Galimberti, V; Garber, J; Gulluoglu, B; Goodwin, P; Harbeck, N; Hayes, D F; Huang, C -S; Huober, J; Khaled, H; Jassem, J; Jiang, Z; Karlsson, P; Morrow, M; Orecchia, R; Osborne, K C; Pagani, O; Partridge, A H; Pritchard, K; Ro, J; Rutgers, E J T; Sedlmayer, F; Semiglazov, V; Shao, Z; Smith, I; Toi, M; Tutt, A; Viale, G; Watanabe, T; Whelan, T J; Xu, B

Annals of Oncology. Jan 01, 2018 29(1):281-282

Azambuja, E de; Piccart-Gebhart, M

Annals of Oncology. Jun2019, Vol. 30 Issue 6, p875-877. 3p.

Curigliano, G; Burstein, H J; P Winer, E; Gnant, M; Dubsky, P; Loibl, S; Colleoni, M; Regan, M M; Piccart-Gebhart, M; Senn, H-J; Thürlimann, B; André, F; Baselga, J; Bergh, J; Bonnefoi, H; Y Brucker, S; Cardoso, F; Carey, L; Ciruelos, E; Cuzick, J; Denkert, C; Di Leo, A; Ejlertsen, B; Francis, P; Galimberti, V; Garber, J; Gulluoglu, B; Goodwin, P; Harbeck, N; Hayes, D F; Huang, C-S; Huober, J; Hussein, K; Jassem, J; Jiang, Z; Karlsson, Per, 1963; Morrow, M; Orecchia, R; Osborne, K C; Pagani, O; Partridge, A H; Pritchard, K; Ro, J; Rutgers, E J T; Sedlmayer, F; Semiglazov, V; Shao, Z; Smith, I; Toi, M; Tutt, A; Viale, G; Watanabe, T; Whelan, T J; Xu, B

Annals of oncology : official journal of the European Society for Medical Oncology. 28(8):1700-1712

de Azambuja, E; Agostinetto, E; Procter, M; Eiger, D; Pondé, N; Guillaume, S; Parlier, D; Lambertini, M; Desmet, A; Caballero, C; Aguila, C; Jerusalem, G; Walshe, J M; Frank, E; Bines, J; Loibl, S; Piccart-Gebhart, M; Ewer, M S; Dent, S; Plummer, C; Suter, T

ESMO Open
de Azambuja, E; Agostinetto, E; Procter, M; Eiger, D; Pondé, N; Guillaume, S; Parlier, D; Lambertini, M; Desmet, A; Caballero, C; Aguila, C; Jerusalem, G; Walshe, J M; Frank, E; Bines, J; Loibl, S; Piccart-Gebhart, M; Ewer, M S; Dent, S; Plummer, C; ... (2023). Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial. ESMO open, 8(1), p. 100772. BMJ 10.1016/j.esmoop.2022.100772

Coates, AS; Winer, EP; Goldhirsch, A; Gelber, RD; Gnant, M; Piccart-Gebhart, M; Thuerlimann, B; Senn, H-J

ANNALS OF ONCOLOGY. 26(8):1533-1546

Holmes, E; Di Cosimo, S; Swaby, RF; Untch, M; Jackisch, C; Lang, I; Smith, I; Boyle, F; Xu, B; Barrios, CH; Kwong, A; Perez, EA; Azim, HA; Kim, SB; Kuemmel, S; Huang, CS; Vuylsteke, P; Hsieh, RK; Gorbunova, V; Gelber, RD; Eidtmann, H; Baselga, J; Eniu, A; Dreosti, L; Tavartkiladze, N; de Azambuja, E; Holmes, AP; Piccart-Gebhart, M

The Lancet Oncology. 15:1137-1146

Oakman, C; Francis, P A.; Crown, J; Quinaux, E; Buyse, M; De Azambuja, E; Margeli Vila, M; Andersson, M; Nordenskjöld, Bo; Jakesz, R; Thuerlimann, B; Gutierrez, J; Harvey, V; Punzalan, L; DellOrto, P; Larsimont, D; Steinberg, I; Gelber, R D.; Piccart-Gebhart, M; Viale, G; Di Leo, A

Annals of Oncology. 24(5):1203-1211

Kwong, A; Baselga, J; Gomez, H; Dinh, P; Fauria, K; Van Dooren, V; Aktan, G; Goldhirsch, A; Chang, TW; Horvath, Z; Coccia-Portugal, M; Domont, J; Tseng, LM; Kunz, G; Sohn, JH; Semiglazov, V; Lerzo, G; Palacova, M; Probachai, V; Pusztai, L; Untch, M; Gelber, RD; Piccart-Gebhart, M; NeoALTTO Study Team; Bradbury, I; Eidtmann, H; Di Cosimo, S; de Azambuja, E; Aura, C

The Lancet. 379:633-640

Curigliano, G; Burstein, H J; Winer, E P.; Gnant, M; Dubsky, P; Loibl, S; Colleoni, M; Regan, M M; Piccart-Gebhart, M; Senn, H -J; Thürlimann, B; 2017, Panel Members of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer

Annals of Oncology. Jul2019, Vol. 30 Issue 7, p1181-1181. 1p.

Shi, W; Jiang, T; Nuciforo, P; Hatzis, C; Holmes, E; Harbeck, N; Sotiriou, C; Peña, L; Loi, S; Rosa, D D; Chia, S; Wardley, A; Ueno, T; Rossari, J; Eidtmann, H; Armour, A; Piccart-Gebhart, M; Rimm, D L; Baselga, J; Pusztai, L

Annals of Oncology. Jun2019, Vol. 30 Issue 6, p1018-1018. 1p.

Curigliano, G; Burstein, HJ; Winer, EP; Gnant, M; Dubsky, P; Loibl, S; Colleoni, M; Regan, MM; Piccart-Gebhart, M; Senn, H-J

ANNALS OF ONCOLOGY. 29(10):2153-2153

Shi W; Jiang T; Nuciforo P; Hatzis C; Holmes E; Harbeck N; Sotiriou C; Peña L; Loi S; Rosa DD; Chia S; Wardley A; Ueno T; Rossari J; Eidtmann H; Armour A; Piccart-Gebhart M; Rimm DL; Baselga J; Pusztai L

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: PubMed not MEDLINE

Buisseret L; Research Centre, University of Montreal Hospital, Montréal, Canada; Montreal Cancer Institute, Montréal, Canada; Faculty of Pharmacy, Université de Montréal, Montréal, Canada; Molecular Immunology Unit, Brussels, Belgium; Breast Cancer Translational Research Laboratory J-C Heuson, Brussels, Belgium.; Pommey S; Research Centre, University of Montreal Hospital, Montréal, Canada; Montreal Cancer Institute, Montréal, Canada; Faculty of Pharmacy, Université de Montréal, Montréal, Canada.; Allard B; Research Centre, University of Montreal Hospital, Montréal, Canada; Montreal Cancer Institute, Montréal, Canada; Faculty of Pharmacy, Université de Montréal, Montréal, Canada.; Garaud S; Molecular Immunology Unit, Brussels, Belgium.; Bergeron M; Research Centre, University of Montreal Hospital, Montréal, Canada; Montreal Cancer Institute, Montréal, Canada; Faculty of Pharmacy, Université de Montréal, Montréal, Canada.; Cousineau I; Research Centre, University of Montreal Hospital, Montréal, Canada; Montreal Cancer Institute, Montréal, Canada; Faculty of Pharmacy, Université de Montréal, Montréal, Canada.; Ameye L; Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Bareche Y; Breast Cancer Translational Research Laboratory J-C Heuson, Brussels, Belgium.; Paesmans M; Data Centre, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Crown JPA; Medical Oncology, Vincent's University Hospital, Dublin, Ireland.; Di Leo A; Medical Oncology Department, Hospital of Prato, Prato, Italy.; Loi S; Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, Melbourne, Australia.; Piccart-Gebhart M; Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Willard-Gallo K; Molecular Immunology Unit, Brussels, Belgium.; Sotiriou C; Breast Cancer Translational Research Laboratory J-C Heuson, Brussels, Belgium.; Stagg J; Research Centre, University of Montreal Hospital, Montréal, Canada; Montreal Cancer Institute, Montréal, Canada; Faculty of Pharmacy, Université de Montréal, Montréal, Canada. Electronic address: john.stagg@umontreal.ca.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

SEMINARS IN ONCOLOGY; FEB 1999, 26 1, p22-p25, 4p. Supplement: 3